Pharmacometrics : Nonlinear mixed effect models in Statistics. Department of Statistics Ewha Womans University Eun-Kyung Lee

Similar documents
Estimation and Model Selection in Mixed Effects Models Part I. Adeline Samson 1

Extension of the SAEM algorithm for nonlinear mixed models with 2 levels of random effects Panhard Xavière

SAEMIX, an R version of the SAEM algorithm for parameter estimation in nonlinear mixed effect models

Stochastic approximation EM algorithm in nonlinear mixed effects model for viral load decrease during anti-hiv treatment

F. Combes (1,2,3) S. Retout (2), N. Frey (2) and F. Mentré (1) PODE 2012

Fitting PK Models with SAS NLMIXED Procedure Halimu Haridona, PPD Inc., Beijing

Description of UseCase models in MDL

Nonlinear random effects mixture models: Maximum likelihood estimation via the EM algorithm

Correction of the likelihood function as an alternative for imputing missing covariates. Wojciech Krzyzanski and An Vermeulen PAGE 2017 Budapest

Evaluation of the Fisher information matrix in nonlinear mixed eect models without linearization

METHODS FOR POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS

Heterogeneous shedding of influenza by human subjects and. its implications for epidemiology and control

1Non Linear mixed effects ordinary differential equations models. M. Prague - SISTM - NLME-ODE September 27,

Inflammation and organ failure severely affect midazolam clearance in critically ill children

Extension of the SAEM algorithm for nonlinear mixed. models with two levels of random effects

TMDD Model Translated from NONMEM (NM- TRAN) to Phoenix NLME (PML)

Pharmacokinetics Introduction to

DESIGN EVALUATION AND OPTIMISATION IN CROSSOVER PHARMACOKINETIC STUDIES ANALYSED BY NONLINEAR MIXED EFFECTS MODELS

Extension of the SAEM algorithm to left-censored data in nonlinear mixed-effects model: application to HIV dynamics model

Non-linear mixed-effects pharmacokinetic/pharmacodynamic modelling in NLME using differential equations

The estimation methods in Nonlinear Mixed-Effects Models (NLMM) still largely rely on numerical approximation of the likelihood function

A Novel Screening Method Using Score Test for Efficient Covariate Selection in Population Pharmacokinetic Analysis

The general concept of pharmacokinetics

Nonlinear mixed-effects models using Stata

Confidence and Prediction Intervals for Pharmacometric Models

Nonlinear Mixed Effects Models

A comparison of estimation methods in nonlinear mixed effects models using a blind analysis

Research Article. Multiple Imputation of Missing Covariates in NONMEM and Evaluation of the Method s Sensitivity to η-shrinkage

3 Results. Part I. 3.1 Base/primary model

A New Approach to Modeling Covariate Effects and Individualization in Population Pharmacokinetics-Pharmacodynamics

Integration of SAS and NONMEM for Automation of Population Pharmacokinetic/Pharmacodynamic Modeling on UNIX systems

Robust design in model-based analysis of longitudinal clinical data

Parameter Estimation in Nonlinear Mixed Effect Models Using saemix, an R Implementation of the SAEM Algorithm

Longitudinal + Reliability = Joint Modeling

Between-Subject and Within-Subject Model Mixtures for Classifying HIV Treatment Response

Estimation, Model Selection and Optimal Design in Mixed Eects Models Applications to pharmacometrics. Marc Lavielle 1. Cemracs CIRM logo

Multicompartment Pharmacokinetic Models. Objectives. Multicompartment Models. 26 July Chapter 30 1

Non-Linear Mixed-Effects Models with Stochastic Differential Equations: Implementation of an Estimation Algorithm

Case Study in the Use of Bayesian Hierarchical Modeling and Simulation for Design and Analysis of a Clinical Trial

Estimating Nonlinear Mixed-Effects Models by the Generalized Profiling Method and its Application to Pharmacokinetics

Modelling a complex input process in a population pharmacokinetic analysis: example of mavoglurant oral absorption in healthy subjects

Population Approach. Pharmacokinetics. Analysis Approaches. Describing The Signal and the Noise

Evaluation of the Fisher information matrix in nonlinear mixed effect models using adaptive Gaussian quadrature

Hierarchical expectation propagation for Bayesian aggregation of average data

STAT 5500/6500 Conditional Logistic Regression for Matched Pairs

Accurate Maximum Likelihood Estimation for Parametric Population Analysis. Bob Leary UCSD/SDSC and LAPK, USC School of Medicine

PK-QT analysis of bedaquiline : Bedaquiline appears to antagonize its main metabolite s QTcF interval prolonging effect

NONLINEAR MODELS IN MULTIVARIATE POPULATION BIOEQUIVALENCE TESTING

Basic Concepts in Population Modeling, Simulation, and Model-Based Drug Development Part 2: Introduction to Pharmacokinetic Modeling Methods

Challenges in modelling the pharmacokinetics of isoniazid in South African tuberculosis patients

Linear, Generalized Linear, and Mixed-Effects Models in R. Linear and Generalized Linear Models in R Topics

Estimating terminal half life by non-compartmental methods with some data below the limit of quantification

Restricted Maximum Likelihood in Linear Regression and Linear Mixed-Effects Model

Research Article. Jacob Leander, 1,2 Joachim Almquist, 1,3 Christine Ahlström, 4 Johan Gabrielsson, 5 and Mats Jirstrand 1,6

Evaluation of bootstrap methods for estimating uncertainty of parameters in nonlinear mixedeffects

Biostat 2065 Analysis of Incomplete Data

Nonparametric Bayes approach for a semimechanistic pharmacodynamic model

Mixed effect model for the spatiotemporal analysis of longitudinal manifold value data

MA/ST 810 Mathematical-Statistical Modeling and Analysis of Complex Systems

Principles of Covariate Modelling

Model Selection in Bayesian Survival Analysis for a Multi-country Cluster Randomized Trial

- 1 - By H. S Steyn, Statistical Consultation Services, North-West University (Potchefstroom Campus)

Population Design in Nonlinear Mixed Effects Multiple Response Models: extension of PFIM and evaluation by simulation with NONMEM and MONOLIX

Bayesian pharmacometric modeling with BUGS, NONMEM and Stan

Modeling biological systems - The Pharmaco-Kinetic-Dynamic paradigm

Nonlinear pharmacokinetics

Mixed effects models

Estimation of AUC from 0 to Infinity in Serial Sacrifice Designs

Default Priors and Effcient Posterior Computation in Bayesian

Plot of Laser Operating Current as a Function of Time Laser Test Data

Analysis of Incomplete Non-Normal Longitudinal Lipid Data

EMPIRICAL DATA SETS in human fatigue and performance. Nonlinear Mixed-Effects Modeling: Individualization and Prediction

Pharmacokinetic-Pharmacodynamic Modeling and Simulation

Beka 2 Cpt: Two Compartment Model - Loading Dose And Maintenance Infusion

The equivalence of the Maximum Likelihood and a modified Least Squares for a case of Generalized Linear Model

Noncompartmental vs. Compartmental Approaches to Pharmacokinetic Data Analysis Paolo Vicini, Ph.D. Pfizer Global Research and Development David M.

arxiv: v1 [stat.me] 10 Apr 2013

Chapter 4 Multi-factor Treatment Designs with Multiple Error Terms 93

Assessing the Effect of Prior Distribution Assumption on the Variance Parameters in Evaluating Bioequivalence Trials

Empirical Likelihood Methods for Two-sample Problems with Data Missing-by-Design

Joint modeling of longitudinal and repeated time-to-event data using nonlinear mixed-effects models and the SAEM algorithm

LONGITUDINAL DATA ANALYSIS

Noncompartmental vs. Compartmental Approaches to Pharmacokinetic Data Analysis Paolo Vicini, Ph.D. Pfizer Global Research and Development David M.

Introduction to Statistical Population Modeling and Analysis for Pharmacokinetic Data

Test Strategies for Experiments with a Binary Response and Single Stress Factor Best Practice

Covariate Model Building in Nonlinear Mixed Effects Models

A Bayesian Nonparametric Approach to Monotone Missing Data in Longitudinal Studies with Informative Missingness

Multilevel Statistical Models: 3 rd edition, 2003 Contents

University of North Carolina at Chapel Hill

PHARMACOKINETIC DERIVATION OF RATES AND ORDERS OF REACTIONS IN MULTI- COMPARTMENT MODEL USING MATLAB

Statistical Methods. Missing Data snijders/sm.htm. Tom A.B. Snijders. November, University of Oxford 1 / 23

Measurement error as missing data: the case of epidemiologic assays. Roderick J. Little

Influence of covariate distribution on the predictive performance of pharmacokinetic models in paediatric research

Testing for bioequivalence of highly variable drugs from TR-RT crossover designs with heterogeneous residual variances

Introduction to Bayesian Statistics and Markov Chain Monte Carlo Estimation. EPSY 905: Multivariate Analysis Spring 2016 Lecture #10: April 6, 2016

The pan Package. April 2, Title Multiple imputation for multivariate panel or clustered data

Approaches to Modeling Menstrual Cycle Function

A Bayesian decision-theoretic approach to incorporating pre-clinical information into phase I clinical trials

Obnoxious lateness humor

Basics of Modern Missing Data Analysis

Transcription:

Pharmacometrics : Nonlinear mixed effect models in Statistics Department of Statistics Ewha Womans University Eun-Kyung Lee 1

Clinical Trials Preclinical trial: animal study Phase I trial: First in human, small number of healthy v olunteers, dose finding Phase II/III trial: First in patient. Large number of patie nts. Prepare for FDA approval 2

Phase I clinical trial first in human small number of healthy volunteers, usually 10~20 Purpose find the right dose for human check toxicity After administration, collect the following information Cp: the drug concentration in blood Time: usually for 24 hours Effect: the effect of drug (eg. Blood pressure for hypertension drug) 3

Pharmacometrics PK PD

Schematics of PK Absorption Distribution Metabolism Elimination 5

Schematics of PK and PD PD Efficacy Toxicity PK Tissue (Effect site) Distribution Drug admin Absorption Blood Metabolism Excretion 6

Theophylline 7

One-comp model: Oral admin. with 1 st order absorp. K a K e Elimination X GI Dose X B K a : 1 st order constant absorption rate Data : C t, t, dose Parameters : K a, K e, V K e : elimination constant rate V : volume of distribution (theoretical volume that total amount of admin. drug would have to occupy to provide the same concentration; large V, more diluted in the blood) Cl : clearance

two-comp model

three-comp model

Population approach 1. Structural sub-model Overall trend using fixed-effect parameters 11

Population approach 2. Statistical sub-model 1) Intra-individual variability 12

Population approach 2) Inter-individual variability C ij : concentration of the ith patient and the jth timepoint K ai : absorption rate of the ith patient V i : volume of distribution of the ith patient K ei : elimination constant rate of the ith patient 13

Population approach 3. Covariance sub-model The relationship between covariate and model par ameter! Nonlinear mixed effect model with covariates 14

PK Model Individual level model Population level model y ij : measurement of i th subject at time t ij D i : dose t ij : time x i : covariates(weight, height, age, etc) θ : PK parameter(v, CL, Ka, etc) 15

Estimation Methods in NONMEM linear approximation approach First order method (FO) First order conditional method (FOCE) Laplacian method (Laplacian) EM algorithm based approach Iterative two stage (ITS) Important Sampling method (IMP) IMP assisted by mode a posteriori (IMPMAP) Stochastic approximation EM(SAEM) Bayesian approach 16

References for estimation methods Dempster, A. P., Laird N., and Rubin, D. B (1977) Maximum likelihood from incomplete data via the EM algorithm Laird, N. M. and Ware, J. H (1982) Random-effects models for longitudinal data Wu, C. F. (1983) On the convergence properties of the EM algorithm Lindstorm, M.J., and Bates, D. M(1988) Newton-Raphson and EM algorithms for linear mixed effects models for repeated-measures data Delyon, B., Laville, M., and Moulines, E.(1990) Convergence of a stochastic approximation version of the EM algorithm Lindstorm, M.J., and Bates, D.M(1990) Non-linear mixed-effects models for repeatedmeasures data Wolfinger, R. (1993) Laplace s approximation for nonlinear model Pinheiro, J.C. and Bates, D.M (1994) Approximations to the loglikelihood function in the nonlinear mixed effect model Davidian, M and Giltinan, D. M (1995) Nonlinear Models for Repeated Measurement Data Walker, S (1996) An EM algorithm for Nonlinear Random Effects Models Kuhn, E., and Lavielle, M. (2004) Coupling a stochastic approximation version of EM with a MCMC procedure Kuhn, E., and Lavielle, M.(2005) Maximum likelihood estimation in nonlinear mixed effects models Lavielle, M., and Meza, C. (2007) A parameter expansion version of the SAEM algorithm Meza, C., Jaffrezic, F., and Foulley, J-L (2007) REML estimation of variance parameters in nonlinear mixed effects models using the SAEM algorithm 17

Results from NONMEM fitting 1. Estimates of parameters PK/PD population parameter Inter-individual variablility Intra-individual variablility 2. Predictions PRED: predictive values without random effect ( when ) EBE: empirical Bayesian estimate of IPRED: individual level predicted values ( when ) 3. Residuals RES: residuals WRES: weighted residuals(for FO method) CWRES: conditional weighted residual (for FOCE method) 4. Covariates, TIME, DV, 18

Graphical Method: Prediction-based(1) 1. Prediction-based : PRED, IPRED, etc. PRED vs DV(obs) plot with line of identity (black line) lines between points for an individual ID values for outer edges of data Regression line (red line) IPRED vs DV plot Source: Intermediate NONMEM 7 Workshop, 2010, Seoul, Korea 19

Graphical Method: Residual-based(1) 2. Residual-based : RES, WRES, CWRES, etc. WRES (weighted residual) : use for FO method CWRES (conditional WRES) : use for FOCE method 20

Graphical Method: Residual-based(2) TIME vs. residual plot with lines between points for an individual ID values for outer edges of data line of y=0 (black line) lowess line line (red line) PRED vs. residual plot Covariate vs. residual plot Source: Intermediate NONMEM 7 Workshop, 2010, Seoul, Korea 21

Graphical Method: Residual-based(3) Estimation method vs. prediction/residual in NONMEM Estimation method PRED RES Weighted RES FO NPRED NRES NWRES FO INTER PREDI RESI WRESI FOCE CPRED CRES CWRES FOCE INTER CPREDI CRESI CWRESI MC based EPRED ERES ECWRES MC based INTER EPRED ERES EWRES MC based NPDE 22

Graphical Method: Residual-based(4) Source: Intermediate NONMEM 7 Workshop, 2010, Seoul, Korea 23

Graphical Method: Residual-based(5) Source: Intermediate NONMEM 7 Workshop, 2010, Seoul, Korea 24

Graphical Method: Residual-based(6) Source: Intermediate NONMEM 7 Workshop, 2010, Seoul, Korea 25

Shiny : Explore NONMEM data 26

Shiny : Explore NONMEM output 27

Shiny : Explore NONMEM output 28

Theophylline 29

Theophylline 30

Graphical Method: Simulation-based(1) Data Model : observed value, ith subject jth observation : observed time of ith subject jth observation : covariates of ith subject Estimate 31

Graphical Method: Simulation-based(2) Simulated data from model : estimates of Simulate data from 32

VPC : example Source: http://www.page-meeting.org/?abstract=1434 33

VPC : Visual Predictive Checks (1) Step 1: Binning TIME data Make G intervals with Binning strategy Have similar amount of data in each bin No need binning if observation times are same between subjects 34

VPC : Visual Predictive Checks (2) Step 2: find PI of the original data Find 5%, 50%, 95% percentile of Also find median(50%percentile) of for each g=1,, G for each g=1,, G g med(tij) 5% percentile 1 2 50% percentile 95% percentile G * Prediction Interval(PI) of each bin is 5% percentile and 95% percentile 35

VPC : Visual Predictive Checks (3) Step 3: find PI of the simulation data Find 5%, 50%, 95% percentile of for each g=1,, G g 5% percentile 1 2 50% percentile 95% percentile G 36

VPC : Visual Predictive Checks (4) Step 4: find CI of 5%, 50%, and 95% percentile of the si mulation data (1) Find 5%, 50%, 95% percentile of for each g=1,, G and each k=1,,k 5% percentile 50% percentile 95% percentile k g 1 2 K k g 1 2 K k g 1 2 K 1 1 1 2 2 2 G G G 37

VPC : Visual Predictive Checks (5) Step 4: find CI of 5%, 50%, and 95% percentile of the si mulation data (2) 5% percentile k 1 2 K g 1 2 G Find 2.5% and 97.5% percentile of CI of 5% percentile of the simulation data g 2.5% percentile 1 2 97.5% percentile G 38

VPC : Visual Predictive Checks (6) * Repeat this procedure for 50% and 95% percentile CI of 50% percentile of the simulation data g 2.5% percentile 1 2 G 97.5% percentile CI of 95% percentile of the simulation data g 2.5% percentile 1 2 97.5% percentile G 39

VPC : Visual Predictive Checks (7) Scatter VPC Make scatter plot of and with 3 lines - vs. - vs. - vs. Source: http://www.page-meeting.org/?abstract=1434 40

VPC : Visual Predictive Checks (8) Percentile VPC Make plot with 6 lines - vs. - vs. - vs. - vs. - vs. - vs. Source: http://www.page-meeting.org/?abstract=1434 41

VPC : Visual Predictive Checks (9) Confidence Interval VPC Make plot with 3 lines and 3 areas - vs. : line - vs. : line - vs. : line - vs. and : area - vs. and : area - vs. and : area 42

VPC : Visual Predictive Checks (10) Confidence Interval VPC Source: http://www.page-meeting.org/?abstract=1434 43

VPC : Visual Predictive Checks (11) Handle covariate in VPC - Need to use stratification of covariate - For each strata, draw VPC plot - Pros - Allows subset of data/model to be inspected - Can increase resolution of model misspecification - Cons - Can dilute the signal - Multiple plot makes diagnostics complex - Use prediction correction 44

Prediction Correction (1) Step 1: Binning TIME/Covariate data Make T intervals with Make C intervals with Overall number of bins: G = T * C t T 1 T 2 T T c X 1 G 1 G 2 G T X 2 G T+1 X C G G 45

Prediction Correction (2) Step 2: Calculate pcvpc(prediction-corrected VPC) where : lower bound of yij from PRED : med(predij in bin g) : typical model prediction 46

Prediction Correction (3) Step 3: calculate pvcvpc(prediction- and variability-cor rected VPC) where 47

Prediction Correction (4) Step 4: plot pcvpc and pvcvpc - Combine all bins and draw one plot in the same manner of VPC - Use pcyij / pvcyij instead of Yij Source: AAPS Journal(2013), Vol.13(2) 143-151 48

Prediction Correction (4) VPC vs. pcvpc Source: AAPS Journal(2013), Vol.13(2) 143-151 49

QVPC/BVPC (1) Data : observed value, ith subject jth observation (including missing) : observed time of ith subject jth observation Rearranged Data 50

QVPC/BVPC(2) Simulated Data from model Bootstrap sample from data 51

QVPC/BVPC(3) Quantified VPC 1. Find 2. Calculate 3. For each t, draw parallel boxes or 52

QVPC/BVPC(3) Quantified VPC Source: J. Pharmacokinet Pharmacodyn(2008), Vol.35:185-202 53

QVPC/BVPC(4) Bootstrap VPC 1. If, impute with 2. Find for each t and k k t 1 2 1 2 K 54

QVPC/BVPC(5) Bootstrap VPC 3. Find 5%, 50%, 95% percentile of t 5% percentile 1 2 50% percentile 95% percentile 55

QVPC/BVPC(6) Bootstrap VPC 4. Draw scatter VPC plot and draw area with and draw line with and 56

Shiny : Visual Predictive Check 57

Shiny : Visual Predictive Check 58

Shiny : Visual Predictive Check 59

Shiny : Visual Predictive Check 60

Shiny : Visual Predictive Check 61

Shiny : Visual Predictive Check 62

fit4nm 63

fit4nm 64

fit4nm 65

fit4nm 66

fit4nm 67

fit4nm 68

fit4nm 69

fit4nm 70

asvpc: example (6) Bin-related weights Distance-related weights CI: 115 bins < 162 CI: 115 bins < 162 15

References Bergstrand, Hooker Wallin, and Karlsson (2011) Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models, The AAPS Journal Vol 13(2) 143-151 Brendel, K., Comets, E., Laffont, C., Laveille, C., and Mentre, F. (2006) Merics for External Model Evaluation with an Application to the Population Pharmacokinetics of Gliclazide, Pharmaceutical Researclh Vol 23(9) 2036-2049 F. Mentre, and S. Escolano (2006) Prediction Discrepancies for the Evaluation of Nonlinear Mixed-Effects Models, Journal of Pharmacokinetics and Pharmacodynamics, 33(3), 345-367 D. D. Wang, and S. Zhang (2012) Standardized Visual Predictive Check Versus Visual Predictive check for Model Evaluation, Journal of Clinical Pharmacology,52, 39-54 P. R. Jadhav, and J. V.S. Gobburu (2005) A New Equivalence Based Metric for Predictive check to Qualify Mixed-Effects Models, The AAPS Journal, 7(3) E523-E531 E. Comets, K. Brendel, and F. Mentre (2008) Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: The npde add-on package for R, Computer Methods and Programs in Biomedicine,90, 154-166 MO Karlsson, and RM savic (2007) Diagnosing Model Diagnostics, Clinical Pharmacology and Therapeutics, 82(1), 17-20 Y. Yano, S.L. Beal, and L. B. Sheiner (2001) Evaluating Pharmacokinetic/Pharmacodynamic Models Using the Posterior Predictive Check, Journal of Pharmacokinetics and Pharmacodynamics, 28(2), 171-192 T.M. Post, J. I. Freijer, B. A. Ploeger, and M. Danhof (2008) Extensions to the Visual Predictive check to facilitate model performance evaluation, Journal of Pharmacokinetics and Pharmacodynamics, 35, 185-202 72

References X. Sun, K. Wu, and D. Cook (2011) PKgraph: An R package for graphically diagnosing population pharmacokinetic models, Computer methods and programs in biomedicine, 104, 461-471 K. Ito and D. Murphy (2013) Application of ggplot2 to Pharmacometric Graphics, CPT: Pharmacometrics and systems Pharmacology, 2, e79 73

Questions 74

75